BioCardia (BCDA) Research & Development (2016 - 2026)
BioCardia (BCDA) reported Research & Development of $893,000 for Q2 2026, down 34.7% from $1.37 million a year earlier and down 27.7% from the prior quarter.
Powered by 
Analysis
BioCardia (BCDA) Research & Development (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, BioCardia's Research & Development came in at $4.19 million, down 20.1% year-over-year; for FY2025, it was $4.96 million, up 13.1% from FY2024.
- Research & Development has a five-year compound annual growth rate of -12.7% (FY2020 to FY2025).
- By year, Research & Development came in at $4.39 million in FY2024 (-43.2%), $7.73 million in FY2023 (-12.5%), $8.83 million in FY2022 (+3.2%) and $8.56 million in FY2021 (-12.8%).
- The Q2 2026 figure ranks as the lowest quarterly Research & Development since Q2 2024.
- Year over year, Research & Development has now declined in each of the last three quarters, with an average decline of 0.9% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q2 2025 (growth of 71.0%); the low point was Q2 2024 (a decline of 65.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.24 million (Q1 2026), $1.13 million (Q4 2025) and $936,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.23 Bn | 1,138.82 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 648.85 Bn | 568.71 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 504.91 Bn | 478.02 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 368.25 Bn | 322.63 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 303.41 Bn | 267.40 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 268.65 Bn | 242.33 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 242.96 Bn | 198.36 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 195.01 Bn | 169.21 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 173.22 Bn | 119.87 Bn | 10.94 Bn | 2.81 Bn |
| 10 | BioCardia | 11.30 Mn | -1.56 Mn | - | 893,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 893,000.00 |
| Mar 31, 2026 | 1.24 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 936,000.00 |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.53 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | 931,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Mar 31, 2024 | 1.24 Mn |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 1.87 Mn |
| Jun 30, 2023 | 2.31 Mn |
| Mar 31, 2023 | 2.38 Mn |
| Dec 31, 2022 | 2.20 Mn |
| Sep 30, 2022 | 2.14 Mn |
| Jun 30, 2022 | 2.30 Mn |
| Mar 31, 2022 | 2.19 Mn |
| Dec 31, 2021 | 2.12 Mn |
| Sep 30, 2021 | 2.24 Mn |
API Access
BioCardia Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=BCDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "BCDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=BCDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();